INVESTOR RELATIONS Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. Press Releases Nov 9, 2021 Curis Reports Third Quarter 2021 Financial Results and Business Update Nov 9, 2021 Curis Announces New Preclinical Data for CI-8993 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting View all press releases >> Events & Presentations B. Riley Fall Best Ideas in Oncology Panel Series —Emerging Targeted Therapies in Acute Myeloid Leukemia Wednesday, December 1, 2021 11:00am EST Add to Calendar Set Email Reminder 12th Annual Jefferies Global Healthcare Conference Thursday, November 18, 2021 3:00am EST View all events & presentations >> Latest Presentation View the latest presentation Investor Alerts Receive the latest alerts via email. Sign up Contact IR Curis, Inc. 128 Spring Street Building C- Suite 500 Lexington, MA 02421 Phone: 617-503-6500 Email: info@curis.com Transfer Agent Computershare 250 Royall Street Canton, MA 02021 URL: www.computershare.com/investor Phone: 877-810-2248 This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Curis' future financial position, business strategy and plans and objectives of management for future operations. We may use such words as "believes," "expects," "anticipates," "plans," "estimates," and similar expressions to identify these forward-looking statements. There are a number of important factors that could cause Curis' actual results to differ materially from these indicated by such forward-looking statements, including those risk factors identified in the filings that Curis' makes from time to time with the SEC (click here to access SEC filings and risk factors contained herein). Curis disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date such statement was first made. © Curis, Inc. 2019 - All Rights Reserved Terms of UsePrivacy Policy , in accordance with our privacy policies. I Understand